CS-526 is an investigational small‑molecule potassium‑competitive acid blocker (P‑CAB) developed for suppression of gastric acid secretion and potential treatment of GERD and peptic ulcer disease. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include CS526. Its PubChem CID is 9833312.
CS-526
| CAS No | 313272-12-7 |
|---|---|
| Molecular Formula | C20H22FN3O |
| Molecular Weight | 339.4 g/mol |
| Synonyms | 7-[(4-fluorophenyl)methoxy]-2,3-dimethyl-1-[[(1S,2S)-2-methylcyclopropyl]methyl]pyrrolo[2,3-d]pyridazine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
CS-526 is an investigational small‑molecule potassium‑competitive acid blocker (P‑CAB) developed for suppression of gastric acid secretion and potential treatment of GERD and peptic ulcer disease.
The listed CAS number is 313272-12-7.
The listed molecular formula is C20H22FN3O.
The listed molecular weight is 339.4 g/mol.
7-[(4-fluorophenyl)methoxy]-2,3-dimethyl-1-[[(1S,2S)-2-methylcyclopropyl]methyl]pyrrolo[2,3-d]pyridazine.
The source lists CS526.